This study examines the effects of remimazolam, a medication used for sedation, in people with stress and anxiety. The purpose is to evaluate how well this medicine works and how comfortable it is when given as a nasal spray.
The treatment involves using a special nasal spray device to deliver two doses of remimazolam. Before giving remimazolam, participants will receive lidocaine (a numbing medicine) through the same type of nasal spray to prevent discomfort in the nose. The total amount of remimazolam used will be 40 milligrams, given as two separate 20-milligram doses.
During the study, medical staff will monitor how sleepy participants become and how they feel after receiving the medication. They will track these effects for several hours after the medication is given. This will help determine if giving remimazolam as a nasal spray could be an effective way to provide sedation.



The Netherlands